Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-24

Clinical Trial Update: Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD) [NA]

View source ↗

Summary

The ACT-AD study is evaluating cerebellar transcranial magnetic stimulation as a treatment for Alzheimer's disease. It is currently recruiting and sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xijing Hospital | Conditions: Alzheimer Disease, Transcranial Magnetic Stimulation | NA | Status: RECRUITING